The western blotting assays of tumor tissue lysates showed that TSN inhibited the PI3K/Akt/mTOR signaling pathway and the expression of MMP-2, cyclin D1, and Bcl-2 proteins (Fig. 6c). The gene discussed is MTOR; the disease is neoplasm.